Cook’s Final Move Apple: Largest U.S. Manufacturing Deal
Apple announces a record onshore manufacturing pact with Broadcom, locking in billions of US-made chips and expanding...
Investing
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
16,583 articles
The $7,500 Limit Almost Nobody Hits, New Data Shows
A fresh look at IRA activity in 2025-26 shows the $7,500 limit almost nobody hits, with average contributions far bel...
Elon Musk Could $165 Billion Payday Sparks Investor Debate
Investors are buzzing about a hypothetical $165 billion payout for Elon Musk tied to SpaceX milestones. Traders say t...
Prediction: Joby Aviation Stock Could Really Soar by 2030
Joby Aviation stock trades near multi-month lows as investors weigh FAA milestones, manufacturing scale, and internat...
FuelCell Energy Sinks 14% After Dilutive Share Sale
FuelCell Energy priced a $225 million stock offering at $21 per share, triggering a 14% slide and dragging peers Bloo...
Tesla BYD Showdown: Here Pick for EV Investors
Tesla and BYD diverge in 2026 as margin expansion and AI investments clash with export growth and battery integration...
Salesforce vs ServiceNow: Buys Back or Buys Companies
Salesforce leans on a sweeping buyback to defend its core, while ServiceNow expands through acquisitions focused on s...
JEPI vs JEPQ: Which Is the Better Buy This July 2026
As July 2026 unfolds, the two JPMorgan income ETFs clash over safety versus yield. This piece weighs performance, pay...
Wall Street Thinks AI Is Slowing. the Trend Is Accelerating
New market data challenge the idea that AI spending is peaking. AI infrastructure is expanding, with implications for...
EthA vs IBIT: Does Ethereum Belong in Your Portfolio?
Two flagship crypto ETFs from BlackRock pit Ethereum’s usage thesis against Bitcoin’s scarcity thesis. Here’s how IBI...
This Undervalued Billion Company Poised for Breakout
NexaTech Holdings, a $40 billion market-cap company, raised its revenue guidance on stronger-than-expected demand, si...
Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...